China E-prescribing Market Size & Outlook, 2023-2030
China e-prescribing market, 2018-2030 (US$M)
Related Markets
China e-prescribing market highlights
- The China e-prescribing market generated a revenue of USD 95.7 million in 2023 and is expected to reach USD 621.8 million by 2030.
- The China market is expected to grow at a CAGR of 30.6% from 2024 to 2030.
- In terms of segment, solution was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
E-prescribing market data book summary
| Market revenue in 2023 | USD 95.7 million |
| Market revenue in 2030 | USD 621.8 million |
| Growth rate | 30.6% (CAGR from 2023 to 2030) |
| Largest segment | Solution |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Solution, Services |
| Key market players worldwide | Oracle Corp, Allscripts Healthcare, Epic Systems Corporation, Athenahealth, NXGN, McKesson Corp, UnitedHealth Group Inc, DrFirst, Surescripts, Veradigm Inc |
Other key industry trends
- In terms of revenue, China accounted for 2.6% of the global e-prescribing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Australia e-prescribing market is projected to lead the regional market in terms of revenue in 2030.
- Australia is the fastest growing regional market in Asia Pacific and is projected to reach USD 811.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
E-Prescribing Market Scope
E-Prescribing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China e-prescribing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to e-prescribing market will help companies and investors design strategic landscapes.
Solution was the largest segment with a revenue share of 58.73% in 2023. Horizon Databook has segmented the China e-prescribing market based on solution, services covering the revenue growth of each sub-segment from 2018 to 2030.
China is considered as one of the high healthcare spending countries, which will expand investment opportunities pertaining to clinical research. Major companies are focusing on eprescription systems, creating more avenues for e-prescription software.
In 2018, China introduced an Inpatient Medication Order Entry System which allowed doctors to recommend medication using a handheld device or computer, with their login details. Pharmacists could access the records to verify the prescription and affix a QR code to the prescription.
Chinese e-prescription market has exhibited significant growth, which can have a positive impact on the Chinese market. China exhibits high growth opportunities, owing to high population and improving healthcare facilities for untargeted medical needs.
Reasons to subscribe to China e-prescribing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China e-prescribing market databook
-
Our clientele includes a mix of e-prescribing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China e-prescribing market , including forecasts for subscribers. This country databook contains high-level insights into China e-prescribing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China e-prescribing market size, by product, 2018-2030 (US$M)
China E-Prescribing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
